Scadden David

Scadden David is listed in filings as Director at Agios Pharmaceuticals, Inc. - Common Stock (AGIO). This profile follows SEC Form 4 activity through Nov 14, 2025, including sale activity. Recent filings connect the profile to Agios Pharmaceuticals, Inc. - Common Stock (AGIO) (AGIO), Editas Medicine Inc (EDIT), and Carisma Therapeutics, Inc. (CARM). The current snapshot covers public activity from Jul 1, 2024 to Nov 14, 2025. Reported amounts are shown as $3.6K to $8.2K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.